PM Share Price Performance
US$188.95
39.77 (26.66%)
4.8% overvalued intrinsic discount
US$180.38
Fair Value
Price US$188.95
AnalystConsensusTarget US$180.38
AnalystLowTarget US$158.00
AnalystHighTarget US$214.07
Fair ValueUS$180.38
Share Pricen/a
Philip Morris International Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 178 Fair Values set on narratives written by author
PM Community Narratives
AN
Fair Value US$180.38 4.8% overvalued intrinsic discount
PM: Share Pullback Will Present Attractive Buying Opportunity Following Guidance Update
1users have liked this narrative
0users have commented on this narrative
83users have followed this narrative
AN
Fair Value US$158 19.6% overvalued intrinsic discount
Regulatory Hurdles And Declining Demand Will Undermine Prospects
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value US$214.07 11.7% undervalued intrinsic discount
Emerging Markets And Urban Growth Will Drive Smoke-Free Expansion
1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
PM: Share Pullback Will Present Attractive Buying Opportunity Following Guidance Update
Key Takeaways Accelerating global adoption of smoke-free products and regulatory support are driving strong growth, margin expansion, and lower regulatory risks for the company. Investment in digital channels and geographic diversification is boosting consumer engagement, sales effectiveness, and earnings stability across emerging and established markets.Read more
694
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
83users have followed this narrative
AN
US$180.38
4.8% overvalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
6.97% p.a.
Profit Margin
28.85%
Future PE
24.93x
Price in 2029
US$226.06
Regulatory Hurdles And Declining Demand Will Undermine Prospects
Key Takeaways Intensifying public health sentiment and regulatory hurdles threaten both traditional and next-generation product growth, challenging future revenue and operating margins. ESG-driven divestment and heavy investment requirements are increasing costs and margin pressure, especially if consumer adoption or regulatory approvals disappoint.Read more
157
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$158
19.6% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
5.71% p.a.
Profit Margin
28.52%
Future PE
22.89x
Price in 2029
US$198.12
Emerging Markets And Urban Growth Will Drive Smoke-Free Expansion
Key Takeaways Aggressive growth in ZYN and smoke-free products, alongside rapid emerging market expansion, is poised to unlock sustained revenue and market share gains beyond expectations. Broadening into wellness, healthcare, and digital platforms diversifies revenue streams and customer engagement, supporting long-term margin expansion and industry leadership.Read more
150
users have viewed this narrative1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
AN
US$214.07
11.7% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
9.16% p.a.
Profit Margin
28.65%
Future PE
28.09x
Price in 2029
US$268.96
Trending Discussion
Recently Updated Narratives
AN
PM: Jefferies Downgrade And Tax Headwinds Will Shape Fairly Valued Outlook
Fair Value: US$180.38 4.8% overvalued intrinsic discount
83 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
PM: Pullback And Guidance Reset Will Shape Post Earnings Share Performance
Fair Value: US$158 19.6% overvalued intrinsic discount
5 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
PM: Recent Share Pullback Will Offer Appealing Long-Term Entry Opportunity
Fair Value: US$214.07 11.7% undervalued intrinsic discount
7 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Philip Morris International Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Apr 22, 2026
- 7.27
- 67.12%
- 27.84%
- -607.6%
About PM
- Founded
- 1987
- Employees
- 84900
- CEO
- WebsiteView website
Philip Morris International Inc. operates as a tobacco company. The company offers cigarettes and smoke-free products, including heat-not-burn, e-vapor, and oral nicotine products under the IQOS, VEEV, and ZYN brands; and consumer accessories, such as lighters and matches. It also offers wellness products. The company was incorporated in 1987 and is headquartered in Stamford, Connecticut.
